PCE
85 episodes - English - Latest episode: about 1 month ago - ★★★★ - 6 ratingsPracticing Clinicians Exchange keeps advanced practice providers up to date with timely interviews from the front lines on current advances and best practices in medicine. Many of the podcasts are available for CE/CME credit.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
How to Implement Earlier Hepatitis B Treatment
March 26, 2024 18:31 - 21 minutes - 19.7 MBIn this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Di...
The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis
March 13, 2024 16:49 - 29 minutes - 27.2 MBIn this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Houston Methodist Hospital Dire...
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening
December 22, 2023 05:00 - 27 minutes - 25.7 MBIn this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV scree...
2023 Audio Recap: Principles of Outpatient COVID-19 Management
May 03, 2023 16:49 - 1 hour - 68.5 MBIn this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Current COVID-19 landscape Rapid antigen tests and PCR tests Risk stratification of patients who have a positive SARS-CoV-2 test Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir) Long COVID Presenters: Renslow Sherer, MD Director, International HIV Training Center Professor of Medicine S...
Empowering Patients to Choose the Right HIV PrEP for Them
April 25, 2023 11:17 - 13 minutes - 12.3 MBIn this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including: Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF Differences in adverse effect profiles between 4 PrEP options Potential for HIV resistance Requirements for compliance and monitoring Evidence in populations with various acquisition ...
Spinal Muscular Atrophy: Improved Recognition and Management of a Rare Disease
April 18, 2023 15:00 - 11 minutes - 11 MBIn this episode, Julie Parsons, MD, discusses the genetic diagnosis of spinal muscular atrophy (SMA), anticipated clinical findings, the importance of newborn screenings, and the next steps to consider after a positive diagnosis is obtained. This high-level overview includes: SMA as an autosomal recessive disease Differences in spinal motor neurons (SMN) 1 and 2 at the time of diagnosis and how these drive severity of disease Important clinical findings in the diagnosis of SMA, as every c...
What’s New in the Treatment of Spinal Muscular Atrophy
April 18, 2023 15:00 - 12 minutes - 11.2 MBIn this episode, Dr. Parsons and Dr. Battista discuss current and emerging medical therapies for the treatment of spinal muscular atrophy (SMA). They review safety, efficacy, and monitoring parameters of current agents, as well as adjuct therapies in the medication pipeline. This high-level overview includes: Review of FDA-approved medical therapies: nusinersen, onasemnogene abeparvovec-xioi, and risdiplam Discussion of the safety, efficacy, and monitoring parameters for FDA approved medic...
Care Coordination in Spinal Muscular Atrophy
April 18, 2023 15:00 - 14 minutes - 12.9 MBIn this episode, Dr. Battista and Dr. Parsons discuss the importance of care guidelines and the multidisciplinary team in the treatment of spinal muscular atrophy (SMA). This overview will include: The role each member of the interdisciplinary team plays in the care of SMA including physical therapists, occupational therapists, and speech therapists The importance of continued, ongoing therapy in addition to medication therapy to provide the greatest improvement in SMA care How to manage ...
Evidence and Guidelines for COVID-19 In-Hospital Management—Expert Answers to Frequently Asked Questions on Coinfections and Transitions of Care
March 27, 2023 16:40 - 14 minutes - 13.6 MBIn this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Viral coinfections such as influenza and RSV New data comparing baricitinib and tocilizumab for patients with severe COVID-19 Management of bacterial and fungal coinfection while incorporating antimicrobial stewardship Tips for transitioning...
Evidence and Guidelines for COVID-19 In-Hospital Management—Expert Answers to Frequently Asked Questions on Supportive Care and Escalation of Therapy
March 27, 2023 14:00 - 20 minutes - 18.6 MBIn this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Supportive care management such as oxygen support, glycemic control, and anticoagulation Escalation of therapy in patients with worsening oxygen requirements Use of remdesivir in patients with renal dysfunction Brief commentary on long COVID...
Tackling Disparities in HIV Prevention
January 19, 2023 21:30 - 9 minutes - 8.31 MBIn this podcast, Susan LeLacheur, DrPH, PA-C, AAHIVS discusses racial disparities in access to HIV prevention (PrEP) and strategies to close these gaps, including: Incorporating comprehensive sexual history into medical appointments and offering PrEP to all sexually active patients Increase awareness of PrEP access programs in communities of color Diversification of the medical workforce Faculty: Susan LeLacheur, DrPH, PA-C, AAHIVS Professor Department of Physician Assistant Studies ...
Key Concepts and Updates for the Diagnosis and Management of NTM-LD
January 10, 2023 19:00 - 14 minutes - 13 MBThis podcast episode is part of a multimedia program reviewing the management of nontuberculous mycobacterial lung disease (NTM-LD). Tune in to hear Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC, and Anne O’Donnell, MD, highlight the diagnostic criteria and optimal treatment strategies in patients with NTM-LD. The overview will include: Recommended assessments and tests to appropriately diagnosis NTM-LD in patients A summary of the current guidelines for the management of NTM-LD, including ...
The Return of the Flu: Prevention and Management Beyond Vaccination in 2022—Expert Answers to Frequently Asked Questions
January 09, 2023 21:00 - 14 minutes - 13.7 MBIn this episode, Tracy Zivin-Tutela, MD, answers audience questions on how best to care for patients at high risk of complications due to influenza from a live virtual meeting series. This episode includes expert insights on: Emerging resistance patterns of currently used antivirals Getting the flu vaccine after treatment with antivirals Use of antivirals in patients who test positive for flu and COVID-19 Techniques and over-the-counter therapies other than yearly vaccination to avoid se...
Podcast 1: The Case for Early Diagnosis and Treatment for MS
December 30, 2022 18:00 - 17 minutes - 16.5 MBIn this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss timely recognition of MS, including insights into why early recognition can lead to early treatment, which can decrease the risk of disability progression and produces better outcomes. Challenges discussed include the variable clinical presentation of MS and the lack of specific tests. The experts also discuss how to avoid missed diagnosis and misdiagnosis. Stephen Krieger, MD: consultant/advisor/speaker: Bio...
Podcast 2: What’s New in Disease-Modifying Therapy
December 30, 2022 18:00 - 16 minutes - 15.4 MBIn this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss the expanding treatment armamentarium for MS, the complexities involved in making treatment selection, patient factors to consider when individualizing treatment, and how best to talk with patients about their options within the context of shared decision-making. Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, ...
Podcast 3: MS in the Long Term
December 28, 2022 21:15 - 16 minutes - 15.3 MBIn this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCS discuss the challenges of managing patients with MS over the long-term, including assessment and management of comorbidities management, differentiating relapse from pseudorelapse, telemedicine, and the important role of NPs and PAs in multidisciplinary care.
How I Approach PrEP in Practice
November 15, 2022 21:00 - 9 minutes - 8.85 MBIn this podcast, Jason E. Farley, PhD, MPH, ANP-BC shares his recommendations on the best ways to implement new HIV PrEP guidelines based on his clinical experiences.
HIV PrEP: Implementing New Guideline Recommendations Into Clinical Practice
August 09, 2022 14:00 - 5 minutes - 5.16 MBIn this podcast, Latesha Elopre, MD, MSPH, discusses how the new CDC recommendations on pre-exposure prophylaxis (PrEP) education, eligibility, and monitoring affect her clinical practice. Contributors: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Latesha Elopre, MD, MSPH, has no relevant financial relationships to disclose.
Improving HIV Prevention in Primary Care: The Evolution of PrEP - Episode 4
July 27, 2022 15:00 - 23 minutes - 21.2 MBIn this podcast, Latesha Elopre, MD, MSPH and Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN answer pressing questions from healthcare professionals who care for patients that may be at risk for HIV infection. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nursing Leadership and Innovation Johns Hopkins University School ...
Improving HIV Prevention in Primary Care: The Evolution of PrEP - Episode 3
July 27, 2022 14:00 - 13 minutes - 12 MBIn this podcast, Latesha Elopre, MD, MSPH discusses options for pre-exposure prophylaxis (PrEP). Listen as she explains best practices for the nonpharmacologic prevention of HIV, as well as oral and injectable pharmacologic PrEP options. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN Endowed Professor of Nursing Leadership and Innovation ...
Improving HIV Prevention in Primary Care: The Evolution of PrEP - Episode 2
July 27, 2022 13:00 - 8 minutes - 7.61 MBIn this podcast, Latesha Elopre, MD, MSPH discusses the new CDC guideline recommendations for pre-exposure prophylaxis (PrEP). Listen as she explains the updated eligibility criteria, assessing indications for PrEP, and best practices for HIV/antibody testing. Presenter: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nursing Leade...
Improving HIV Prevention in Primary Care: The Evolution of PrEP - Episode 1
July 27, 2022 12:00 - 10 minutes - 9.91 MBIn this podcast, Latesha Elopre, MD, MSPH discusses inequities in pre-exposure prophylaxis (PrEP) uptake and the importance of sexual health screening. Additionally, Dr Elopre shares her best practices for receiving an adequate sexual health history from her patients. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nurs...
Management of Atopic Dermatitis in Primary Care and Specialty Settings
July 19, 2022 16:00 - 20 minutes - 18.6 MBThis podcast episode is part of a multimedia program discussing the co-management of moderate to severe atopic dermatitis (AD) in the primary care and specialty settings. Tune in to hear Dr Silverberg and NP Victoria Garcia-Albea highlight newly approved agents and the recent expanded labeling of an existing AD therapy, including: Ruxolitinib, a topical JAK inhibitor for mild to moderate AD approved in 2021 Abrocitinib and upadacitinib, oral JAK inhibitors approved in early 2022 for mode...
ASCO 2022: What’s New in Mantle Cell Lymphoma
June 30, 2022 16:00 - 24 minutes - 22.5 MBIn this episode, Tycel J. Phillips, MD, and Amy Goodrich, RN, MSN, CRNP-AC, provide expert insights on key data presented at ASCO 2022 for mantle cell lymphoma regarding: Results from the phase III SHINE study of the addition of ibrutinib the first-line BR followed by rituximab maintenance in older patients with MCL Updated results from the phase II ZUMA-2 study evaluating brexucabtagene autoleucel for patients with R/R MCL Results from a phase I/II study of the ROR1 humanized monoclonal ...
ASCO 2022: Advances in CLL/SLL
June 30, 2022 16:00 - 37 minutes - 34.2 MBIn this episode, John M. Burke, MD, a leading expert, and Amy Esposito, FNP-C provide expert insights on key data presented at the 2022 ASCO annual conference for CLL/SLL regarding: Updated response and safety results after 3 years of follow-up from the phase II CAPTIVATE study of ibrutinib and venetoclax in patients with previously untreated CLL Updated response and remission rates after 4 years of follow-up from a phase II trial of obinutuzumab, ibrutinib, and venetoclax in patients with...
Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer
June 30, 2022 12:00 - 12 minutes - 11.9 MBIn this episode, Sandip Patel, MD shares his thoughts on optimizing immune checkpoint inhibitor (ICI) therapy in advanced non-small-cell lung cancer (NSCLC) and discusses best practices for individualizing therapy decisions and managing adverse events. Topics include: Currently approved ICIs Role of biomarker and PD-L1 testing in advanced NSCLC Strategies to individualize ICI treatment for patients with advanced NSCLC Strategies for identifying and managing immune-related adverse events...
A Nursing Perspective on PARP Inhibitors in Prostate Cancer
June 30, 2022 12:00 - 11 minutes - 10.7 MBIn this episode, Brenda Martone, MSN, ANP-BC, AOCNP describes recent evidence on PARP inhibitor therapy in metastatic castrate-resistant prostate cancer (mCRPC) and discusses best practices for incorporating PARP inhibitors into clinical practice. Topics include: An overview of the PROpel study of olaparib and the TRITON study of rucaparib FDA-approved indications for olaparib and rucaparib Genetic and molecular testing for BRCA1/2 and other HRR mutations Managing adverse events associat...
Nursing Considerations for CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
June 30, 2022 12:00 - 20 minutes - 19.3 MBIn this episode, Julia LaBarbera, MSN, RN, AGACNP-BC, discusses the latest evidence and guidance on how advanced practice providers can optimize patient outcomes with CDK4/6 inhibitors for HR+/HER2- breast cancer. Topics include: An overview of the monarchE study leading to FDA approval of adjuvant abemaciclib Key trial data on abemaciclib, palbociclib, and ribociclib for metastatic HR+/HER2- breast cancer Managing adverse events associated with CDK4/6 inhibitors Promoting adherence to o...
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: An Update from ASCO 2022
June 27, 2022 20:00 - 19 minutes - 18.2 MBIn this episode, Beth Sandy, MSN, CRNP provides her thoughts on key data presented at the 2022 ASCO annual conference relating to immune checkpoint inhibitors in non-small cell lung cancer (NSCLC). Findings covered include: Survival results after 3 years from the phase III Checkmate 9LA study of nivolumab and ipilimumab combined with 2 cycles of chemotherapy vs chemotherapy in previously untreated advanced NSCLC Updated survival and safety results after 5 years from the phase III Checkmate...
Interview With the Experts: Strategies to Overcome SDOH in NVAF Part 1
June 16, 2022 04:00 - 13 minutes - 12.2 MBIn this episode, Keith C. Ferdinand MD, FACC, FAHA, discusses with David S. Kountz, MD, a patient case in which health disparities affected NVAF care and provides strategies to address low health literacy and patient access to direct-acting oral anticoagulant to improve NVAF-related cardiovascular outcomes. Presenters Keith C. Ferdinand, MD, FACC, FAHA Professor of Medicine Tulane Heart and Vascular Institute Tulane University School of Medicine New Orleans, Louisiana David S. Kountz, MD...
Interview with the Experts: Strategies to Overcome SDOH in NVAF Part 2
June 16, 2022 04:00 - 15 minutes - 13.9 MBIn this episode, David S. Kountz, MD, discusses with Keith C. Ferdinand MD, FACC, FAHA, a patient case in which health disparities affected NVAF care and provides patient, provider, and health-system level strategies to address these disparities to improve NVAF-related cardiovascular outcomes. Presenters Keith C. Ferdinand, MD, FACC, FAHA Professor of Medicine Tulane Heart and Vascular Institute Tulane University School of Medicine New Orleans, Louisiana David S. Kountz, MD Professor of ...
Heading Into Migraine Management
June 13, 2022 04:00 - 23 minutes - 21.6 MBIn this podcast episode, 2 migraine experts discuss clinical pearls for individualizing migraine care from diagnosis to ongoing management. They cover patient factors to consider in the differential diagnosis, when choosing an acute treatment, and in making the decision to initiate preventive treatment. This activity is available for CE/CME credit. Claim your credit at pce.is/migraine. Contributors Maureen Moriarty, DNP, ANP-BC Associate Professor Director Malek School of Nursing Professi...
Overview of SDOH in NVAF and CV-Related Outcomes
May 26, 2022 14:40 - 11 minutes - 10.6 MBThis podcast is the first in a series of 3 featuring an multidisciplinary panel of expert faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, David S. Kountz, MD, provides a detailed explanation of the atrial fibrillation paradox and data on the impacts of SDOH on NVAF CV-related outcomes.Review the downloadable slideset and full program at: PCE.is/NVAF. Contributors: Program Director ...
NVAF Management and Future Directions
May 26, 2022 14:05 - 20 minutes - 19 MBThis podcast is the third in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Keith C. Ferdinand, MD, FACC, FAHA, details the effects of SDOH on anticoagulation prescribing in NVAF and provides an overview of areas for future study. Review the downloadable slideset and full program at: PCE.is/NVAF. Contributors: Program Di...
Strategies to Overcome SDOH in NVAF
May 26, 2022 14:00 - 18 minutes - 16.7 MBThis podcast is the second in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Laura Ross PA-C, CLS, dives deeper into the impacts of SODH on NVAF care and provides strategies to address to improve patient care and clinical outcomes in NVAF. Review the downloadable slideset and full program at: PCE.is/NVAF. Contributors: P...
Strategies for Individualizing Management of Inflammatory Bowel Disease: Episode 1
May 16, 2022 12:00 - 24 minutes - 22.3 MBThis podcast is the first in a series of four featuring IBD specialists Drs Anita Afzali, MD, MPH, FACG, AGAF and Nana Bernasko, DNP, CRNP, WHNP-BC. In this episode, the experts discuss the importance early and accurate diagnosis and classification of IBD plays in choosing appropriate and individualized therapies for disease management. Presenters: Anita Afzali, MD, MPH, FACG, AGAF Professor of Clinical Medicine Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease Medical Dire...
Strategies for Individualizing Management of Inflammatory Bowel Disease: Episode 3
May 16, 2022 12:00 - 17 minutes - 16 MBThis podcast is the third in a series of four featuring IBD specialists Drs Anita Afzali, MD, MPH, FACG, AGAF and Nana Bernasko, DNP, CRNP, WHNP-BC. In this episode, our panel of experts review strategies for individualizing care, medication response challenges, the use of therapeutic drug monitoring, and treatment de-escalation strategies. Presenters: Anita Afzali, MD, MPH, FACG, AGAF Professor of Clinical Medicine Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease Medical ...
Strategies for Individualizing Management of Inflammatory Bowel Disease: Episode 2
May 16, 2022 12:00 - 22 minutes - 20.5 MBThis podcast is the second in a series of four featuring IBD specialists Drs Anita Afzali, MD, MPH, FACG, AGAF and Nana Bernasko, DNP, CRNP, WHNP-BC. Our moderator for the series is Mr Rick Davis, PA-C. In this episode, our panel of experts review available medication options and their current place in therapy according to recent evidence and guideline recommendations. Presenters: Anita Afzali, MD, MPH, FACG, AGAF Professor of Clinical Medicine Abercrombie & Fitch Endowed Chair in Inflam...
Strategies for Individualizing Management of Inflammatory Bowel Disease: Episode 4
May 16, 2022 12:00 - 17 minutes - 16.1 MBThis podcast is the last in a series of four featuring IBD Dr Nana Bernasko, DNP, CRNP, WHNP-BC. In this episode, Dr Bernasko reviews the best practices for collaborating with primary care for optimal health maintenance in IBD patients, including cancer screening, bone health, immunizations, and more. Presenter: Nana Bernasko, DNP, CRNP, WHNP-BC Assistant Professor Division of Gastroenterology and Hepatology Department of Medicine Penn State University Medical Center Hershey, Pennsylvan...
Getting Ahead of the Pain: Preventive Options for Migraine
April 05, 2022 14:00 - 26 minutes - 24.8 MBIn this second of two podcasts, 2 experts in migraine provide clinical pearls focused on preventing migraine. Listen as they discuss patient factors that indicate preventive treatment is warranted, the range of available preventive treatments and their use in practice, and strategies for engaging patients in their care. This activity is available for CE/CME credit. Claim your credit at pce.is/migraine. Contributors: Karen A. Williams, DNP, FNP-BC, AQH President KDW Health Management Pensa...
Heading Off the Pain: Acute Treatment of Migraine
April 05, 2022 14:00 - 26 minutes - 24.7 MBIn this first of two podcasts, 2 experts in migraine provide valuable information on the differential diagnosis of migraine, including screening tools and techniques to incorporate into your practice. Additionally, they detail acute treatment options ranging from nonpharmacologic to over-the-counter to novel prescription pharmacologic therapies and discuss their use in the acute migraine management paradigm. This activity is available for CE/CME credit. Claim your credit at pce.is/migraine. ...
Recognition and Initial Management of ITP
April 05, 2022 13:00 - 14 minutes - 13.7 MBIn this first of two podcasts, 2 experts discuss risk factors and current recommendations for the diagnostic workup of ITP, and share strategies for initial management of newly diagnosed disease. Topics including corticosteroid overuse, approaches to improve remission rates, and contemporary concerns with COVID vaccination will be covered.. This activity is available for CE/CME credit. Claim your credit at pce.is/ITP. Contributors: Hanny Al-Samkari, MD Assistant Professor Harvard Medical S...
New Options for Management of Refractory ITP
April 05, 2022 13:00 - 12 minutes - 11.9 MBIn this second of two podcasts, listen as 2 experts discuss novel therapies that target disease pathophysiology, with a focus on individualizing treatment to optimize outcomes for their patients with ITP. Unique considerations of the drug and surgical options are discussed. This activity is available for CE/CME credit. Claim your credit at pce.is/ITP. Contributors: Hanny Al-Samkari, MD Assistant Professor Harvard Medical School Attending Hematologist and Clinical Investigator Division of H...
What’s New in Sickle Cell Disease and Vaso-occlusive Episodes
April 04, 2022 14:08 - 11 minutes - 10.7 MBIn this second of 2 podcasts episodes on the management of painful vaso-occlusive crises in patients with sickle cell disease, listen to Alison Towerman, RN, MSN, CPNP, and Michael R. DeBaun, MD, MPH, discuss available treatment options for the prevention of painful vaso-occlusive events, and provide emergency department and outpatient setting recommendations on the proper use and indications for hydroxyurea, L-glutamine, and P-selecting blocking antibody crizanlizumab. This activity is ava...
Current Understanding of Sickle Cell Disease
April 04, 2022 14:08 - 14 minutes - 13.8 MBIn this first of 2 podcasts episodes, Alison Towerman, RN, MSN, CPNP, and Michael R. DeBaun, MD, MPH, discuss best practices for the management of painful vaso-occlusive crises (VOCs) in patients with sickle cell disease, review the disease pathophysiology, and provide emergency department and outpatient setting recommendations on nonpharmacologic and pharmacologic management of painful VOCs. This activity is available for 0.25 ANCC and 0.25 AAPA credits, with 0.25 credits applicable for p...
Making Sense of the Expanding Options in Metastatic Colorectal Cancer Care: Part 2
March 21, 2022 16:00 - 24 minutes - 22.1 MBIn this second of two podcasts, two oncologists discuss subsequent therapy for metastatic colorectal cancer, and review cases of patients with metastatic colorectal cancer to discuss testing for mutations and biomarkers, appropriate selection of treatment regimens, and management. This activity is available for CE/CME credit. Claim your credit at pce.is/GIGU. Contributors: Joleen Hubbard MD Cathy Eng, MD Stephanie Andrews, MS, APRN-C Ms Andrews: fees for non-CME/CE services: Genentech. ...
Making Sense of the Expanding Options in Metastatic Colorectal Cancer Care: Part 1
March 21, 2022 16:00 - 33 minutes - 30.7 MBIn this first of two podcasts, oncologists discuss the latest evidence that informs how they select first-line treatment regimens for patients with metastatic colorectal cancer. Using cases for a patient-centered approach, they explore the recommended testing for mutations and biomarkers that impact metastatic colorectal cancer, how to plan strategies for incorporating novel agents into the treatment of patients and recommended strategies to identify and manage toxicities of novel agents for...
ASCO Genitourinary Cancers Symposium, 2022: A Focus on Prostate Cancer
March 17, 2022 13:00 - 27 minutes - 25.5 MBIn this podcast, Dr. Alicia Morgans discusses recent data presented at the 2022 ASCO GU Cancers Symposium, including trials evaluating the use of first-line PARP inhibitors in combination with abiraterone for mCRPC, continuation of enzalutamide after progression, and imaging modalities as predictive and prognostic biomarkers. This activity is available for CE/CME credit. Claim your credit at pce.is/ascogu. Contributors: Dr Morgans has disclosed that she has received funds for research sup...
Gastric Cancer: New Strategies, New Therapies, New Hope, Part 2
February 25, 2022 15:33 - 23 minutes - 21.5 MBIn this second of two podcasts, an expert discuss decision making for subsequent line therapy for advanced gastric cancer, and review cases to illustrate practical considerations, followed by a question-and-answer session. This activity is available for CE/CME credit. Claim your credit at pce.is/GIGU. Contributor: David Ilson, MD Dr Ilson: consulting fees: Aeris, Amgen, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Lilly, Merck, Roche, Taiho.
Gastric Cancer: New Strategies, New Therapies, New Hope, Part 1
February 25, 2022 15:32 - 28 minutes - 26.6 MBIn this first of two podcasts, an expert discusses the data supporting their selection of first-line treatments for advanced gastric cancer. A case illustrates key takeaways about molecular markers that can impact choice of therapy in gastric cancer, novel and emerging treatments, and prevention and management of treatment-related toxicities. This activity is available for CE/CME credit. Claim your credit at pce.is/GIGU. Contributor: David Ilson, MD Dr Ilson: consulting fees: Aeris, Amgen...